Five IPOs and 17 SPACs went public this past week. While new filing activity has slowed as the election approaches, four IPOs and four SPACs submitted initial filings.
Leading security software provider McAfee (MCFE) priced slightly below the midpoint to raise $740 million at a $9.4 billion market cap. Taken private by Intel in 2011, McAfee provides...read more
Eucrates Biomedical Acquisition, a blank check company formed by Vedanta Management targeting data-driven healthcare and biotech businesses, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50.
The company is led by Chairman Stelios Papadopoulos, who...read more
Eucrates Biomedical Acquisition, a blank check company formed by Vedanta Management, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering.
The New York, NY-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. At the...read more
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
US IPO Weekly Recap: McAfee leads a 5 IPO week
Five IPOs and 17 SPACs went public this past week. While new filing activity has slowed as the election approaches, four IPOs and four SPACs submitted initial filings. Leading security software provider McAfee (MCFE) priced slightly below the midpoint to raise $740 million at a $9.4 billion market cap. Taken private by Intel in 2011, McAfee provides...read more
Healthcare SPAC Eucrates Biomedical Acquisition prices $100 million IPO at $10
Eucrates Biomedical Acquisition, a blank check company formed by Vedanta Management targeting data-driven healthcare and biotech businesses, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company is led by Chairman Stelios Papadopoulos, who...read more
Healthcare SPAC Eucrates Biomedical Acquisition files for a $100 million IPO
Eucrates Biomedical Acquisition, a blank check company formed by Vedanta Management, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. The New York, NY-based company plans to raise $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. At the...read more